| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Harvard Apparatus Regenerative Technology, Inc. (HRGN) has 8 insiders with recent SEC Form 4 filings, including 6 buys and 4 sells. HRGN is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 280.6K | $420.9K | - | |
| Dir | 18.6K | $27.9K | - | |
| Dir | 18.6K | $27.9K | - | |
| Dir | 18.6K | $27.9K | - | |
| Dir | 18.6K | $27.9K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 11, 2023 | He Junli | CEO | Buy | 1,500 | $5.43 | $8,145.00 | +0.6% | |
| Aug 28, 2023 | He Junli | CEO | Buy | 3,400 | $4.69 | $15,946.00 | +1.4% | |
| Aug 21, 2023 | Shmerling James E. | Director | Buy | 6,864 | $4.35 | $29,858.40 | +40.6% | |
| Aug 18, 2023 | He Junli | CEO | Buy | 8,000 | $4.32 | $34,560.00 | +3.4% | |
| Apr 6, 2023 | Dst Capital LLC | 10% Owner | Buy | 62,500 | $6.00 | $375,000.00 | +1.7% | |
| Dec 12, 2022 | He Junli | Director | Sell | 135 | $6.83 | $922.05 | - | |
| Dec 7, 2022 | Yu Hong | President | Sell | 83,676 | $7.17 | $599,956.92 | -27.3% | |
| Dec 7, 2022 | Dst Capital LLC | 10% Owner | Sell | 1,952 | $7.17 | $13,995.84 | - | |
| Dec 7, 2022 | Chen Jing | Director | Sell | 48,532 | $7.17 | $347,974.44 | -23.1% | |
| May 12, 2022 | Green David | Interim CEO | Buy | 63,345 | $5.92 | $375,002.40 | +66.3% |